Quadria Capital
Finance
Quadria Capital hits final close of second healthcare fund, overshoots target
Singapore-based private equity firm Quadria Capital has closed its second fund at its maximum fund size of $595 million, it ......
Finance
Flashback 2019: VCs snag record sum as PE firms toil hard to cross finish line
Global and domestic Limited Partners (LPs), or institutional investors and affluent individuals, pumped a record amount of money...
Healthcare
Quadria Capital ups stake in healthcare firm, buys out Samara
Quadria Capital, which is raising its second healthcare-focussed private equity vehicle, has doubled down on a portfolio company...
Healthcare
Quadria Capital seals debut deal from new PE fund in Delhi-based drugmaker
Singapore- and Delhi-based private equity firm Quadria Capital is close to striking its debut bet from its new healthcare-focused...
Healthcare
Why Indian bulk-drug makers are attracting greater investor interest
Private equity investors as well as pharmaceutical companies are showing higher interest in the bulk-drugs segment in India, industry...
Finance
Quadria Capital, ING team up to offer loans linked to ESG targets
Healthcare-focussed private equity firm Quadria Capital has secured a commitment from Dutch financial services giant ING Group...
Finance
IFC plans to back healthcare private equity firm Quadria's second fund
International Finance Corporation has proposed a limited partnership investment of up to $25 million (Rs 180.47 crore at current...
Finance
DEG adds another Indian mid-market PE firm to LP portfolio
German development finance institution Deutsche Investitions- und Entwicklungsgesellschaft (DEG) is placing another bet on India. DEG...
Healthcare
Sector watch: Can India's eye-care chains reverse a revenue slowdown?
When Singapore sovereign wealth fund Temasek Holdings came in as a new investor in Dr Agarwal’s Health Care Ltd earlier...
Healthcare
ChrysCap emerges as front runner to invest in Mumbai bulk-drugs maker
Homegrown private equity firm ChrysCapital has emerged as the primary suitor to clinch an investment in a Mumbai-based drug maker,...
